Category: Investor Relations
-
NeuroNode is now an Apple-Approved Assistive Tech Device
Control Bionics is excited to announce that NeuroNode® has been listed as a third-party assistive technology device on Apple’s website. Apple’s inclusion of the NeuroNode in its Apple-approved assistive technologies underscores NueroNode’s versatility and effectiveness. Users can seamlessly integrate the NeuroNode with their Apple devices including iPads, iPhones, and computers, enhancing their ability to communicate…
-
The ALS Association awards a prestigious Assistive Technology Grant to Control Bionics
Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching for new treatments and a cure. The grant enables Control Bionics to amplify…
-
ASX Announcement: Appointment of CEO
Control Bionics Ltd (ASX: CBL) is pleased to announce the appointment of Jeremy Steele as Chief Executive Officer and a member of the board, effective from 19 January 2023.
-
What’s New: NeuroNode Controller App Update
There are been several recent updates to the NeuroNode Controller App, introducing new key features: Profiles, Upper Limit Threshold, 2nd Switch, and Auto Calibration.
-
Control Bionics CEO Rob Wong Speaks with Holly Shields, Business Reporter at Kalkine Media
Want to know what you can look forward to seeing from Control Bionics in the next 12 months? Watch the full interview with Kalkine Media to find out.
-
Control Bionics’ (ASX:CBL) distinct tech feature – ‘Eye gaze combined with EMG switching’
Control Bionics was featured in an article by Kalkine Media discussing our NeuroNode Trilogy and its distinct tech feature. To deliver on our vision of giving a voice to those with physical and speech challenges, we have combined our NeuroNode Trilogy system with eye gaze camera technology to provide our users with a faster, less…
-
Why Control Bionics’ (ASX:CBL) UNO Touch device points to a bright future
Control Bionics was featured in an article by Kalkine Media discussing our new AAC solution, UNO Touch.
-
Control Bionics’ (ASX:CBL) COSMOS Connect: A promise for life-enjoying experiences
Control Bionics was featured in an article by Kalkine Media discussing the company’s latest launch, COSMOS Connect.
-
Featured Article: Control Bionics Limited commences full-scale operations in Japan
Control Bionics was featured in an article on JETRO’s site announcing the expansion of our AAC technology into Japan. Read the full article.
-
Control Bionics Integrates State-of-the-Art Eye Gaze Camera into Product Offerings
Control Bionics is excited to announce the integration of the Hiru eye gaze camera into our AAC solutions. With the addition of the Hiru, Control Bionics will be able to offer the latest in eye gaze technology.
-
Control Bionics (ASX:CBL) delivers solid March quarter with 90% jump in US sales
Control Bionics (ASX:CBL) delivers solid March quarter with 90% jump in US sales.
-
Introducing the Cosmos Connect from Control Bionics
We’re constantly working towards our mission of making life-changing connections which brought us to our latest product offering, the Cosmos Connect.